» Authors » Sonia Dutta

Sonia Dutta

Explore the profile of Sonia Dutta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 171
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Serna-Gallegos T, Dutta S, Crowder C, Wadensweiler P, Whitcomb E, Guaderrama N
Urogynecology (Phila) . 2023 Jun; 30(1):59-64. PMID: 37326287
Importance: The low incidence of de novo overactive bladder (OAB) symptoms after a midurethral sling (MUS) procedure better informs preoperative counseling. Objective: The study aimed to measure the incidence and...
2.
Jeney S, Avelar-Barragan J, Whiteson K, Chang J, Dutta S, Lane F
Female Pelvic Med Reconstr Surg . 2021 Oct; 28(4):213-219. PMID: 34608030
Objective: The aims of this study were to describe the fecal relative abundance of potentially uropathogenic bacteria and to analyze antibiotic resistance genes before and after fecal microbiota transplantation in...
3.
Jeney S, Lane F, Oliver A, Whiteson K, Dutta S
Obstet Gynecol . 2020 Sep; 136(4):771-773. PMID: 32925627
No abstract available.
4.
Chen C, Cox J, Yuan C, Thomaier L, Dutta S
BMC Fam Pract . 2019 May; 20(1):70. PMID: 31122187
Background: Pelvic floor disorders including urinary incontinence (UI) and pelvic organ prolapse (POP) are common conditions; however, most women with these symptoms do not seek care. Failure to seek care...
5.
Sudol N, Dutta S, Lane F
Int Urogynecol J . 2018 Jul; 30(7):1173-1178. PMID: 29971468
Introduction And Hypothesis: The pubovaginal sling (PVS) dates to the 1940s as an efficacious surgical treatment for stress urinary incontinence (SUI). Recently, it has been replaced by the midurethral sling...
6.
Dutta S, Lane F
Ther Adv Urol . 2018 Apr; 10(5):157-163. PMID: 29623107
Background: Treatment options for refractory recurrent urinary tract infections (UTI) are limited; therefore, we sought to determine if intravesical instillations with heparin effectively treat recurrent UTIs. Methods: Patients at an...
7.
Gunderson C, Dutta S, Fader A, Maniar K, Nasseri-Nik N, Bristow R, et al.
Gynecol Oncol . 2013 Dec; 132(1):33-7. PMID: 24316307
Objective: To determine the response of complex atypical hyperplasia (CAH) and well differentiated endometrioid adenocarcinoma of the uterus (WDC) to progestin therapy and whether pre-treatment estrogen and progesterone receptor status...
8.
Dutta S, Wang F, Wu H, Mukherjee T, Fishman D
Gynecol Oncol . 2011 Jul; 123(1):129-37. PMID: 21782227
Objectives: Our previous report has implicated the involvement of VEGF-VEGFR-2 h signaling in LPA-induced EOC invasion. However, the mechanism by which LPA regulates VEGF and VEGFR-2 expression remains to be...
9.
Dutta S, Wang F, Fishman D
Biomark Med . 2010 Jun; 4(3):437-9. PMID: 20550476
No abstract available.
10.
Dutta S, Wang F, Phalen A, Fishman D
Cancer Biol Ther . 2010 Apr; 9(9):668-77. PMID: 20372062
Despite advances in surgical technologies and the development of more effective chemotherapeutics, epithelial ovarian cancer (EOC) remains the leading cause of death in women with gynecologic malignancies. The high mortality...